Arkolith/Insider Trading/CRDF/Form 4

Levine James E.

Chief Financial OfficerCardiff Oncology, Inc. (CRDF) · full profile →Form 4 · filed Dec 18, 2024
Net Buying
Open-Market Buys
$37K
Open-Market Sells
$0
Net Open-Market Flow
$37K
Transactions
3
3 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Dec 18, 2024Buy(P)2K$5.00$12K68K
Dec 17, 2024Buy(P)3K$5.42$15K65K
Dec 16, 2024Buy(P)3K$3.83$10K63K

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000950170-24-137938) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML

Keep exploring

Connected pages for Cardiff Oncology, Inc.

Build

Ask your agent about CRDF insider filings

This filing is the Follow view. The Build view lets your agent pull every Form 4 for the issuer, the net open-market picture over 90 days, and the accession behind each row, through REST or MCP.

Get a key Compare plansForm 4 data
Copy-paste
curl -H "Authorization: Bearer YOUR_API_KEY" \
  "https://arkolith.com/api/v1/filing/0000950170-24-137938"
Ask your agent
Use Arkolith to summarize insider buying and selling at Cardiff Oncology, Inc.
over the last 90 days and cite the filings.